Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

(2015) Matti Annala et al.   Oncotarget

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

(2014) Andrew J Vickers et al.   BMC Medicine

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer

(2013) K. A. Leinonen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts

(2012) Hong Lou et al.   HUMAN GENETICS

Levels of Beta-Microseminoprotein in Blood and Risk of Prostate Cancer in Multiple Populations

(2012) Christopher A. Haiman et al.   JNCI-Journal of the National Cancer Institute

Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

(2011) Serban Nacu et al.   BMC Medical Genomics

Evaluation of Multiple Risk–Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men

(2011) Robert J. Klein et al.   EUROPEAN UROLOGY

Polymorphisms at the Microseminoprotein-  Locus Associated with Physiologic Variation in  -Microseminoprotein and Prostate-Specific Antigen Levels

(2010) X. Xu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A Common Prostate Cancer Risk Variant 5' of Microseminoprotein-  (MSMB) Is a Strong Predictor of Circulating  -Microseminoprotein (MSP) Levels in Multiple Populations

(2010) K. M. Waters et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer

(2010) K. A. Leinonen et al.   CLINICAL CANCER RESEARCH

A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression

(2010) Bin Xu et al.   PROSTATE

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3

(2010) A Dahlman et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study

(2009) N. J. Camp et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

(2009) H. Lou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chimeric transcript discovery by paired-end transcriptome sequencing

(2009) C. A. Maher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Beta-Microseminoprotein in Serum Correlates With the Levels in Seminal Plasma of Young, Healthy Males

(2008) C. Valtonen-Andre et al.   JOURNAL OF ANDROLOGY

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple loci identified in a genome-wide association study of prostate cancer

(2008) Gilles Thomas et al.   NATURE GENETICS

Multiple newly identified loci associated with prostate cancer susceptibility

(2008) Rosalind A Eeles et al.   NATURE GENETICS